Your browser doesn't support javascript.
loading
Successful Treatment of Multiple Multidrug Resistant Intracranial Tuberculomata.
Sullivan, Richard P; Goldberg, Hazel F; Mellick, Ross S; Post, Jeffrey J.
Afiliación
  • Sullivan RP; Department of Infectious Diseases, Prince of Wales Hospital, Sydney, NSW, Australia; Prince of Wales Clinical School, University of NSW, Sydney, NSW, Australia.
  • Goldberg HF; Department of Respiratory Medicine, Prince of Wales Hospital, Sydney, NSW, Australia.
  • Mellick RS; Institute of Neurological Sciences, Prince of Wales Hospital, Sydney, NSW, Australia.
  • Post JJ; Department of Infectious Diseases, Prince of Wales Hospital, Sydney, NSW, Australia; Prince of Wales Clinical School, University of NSW, Sydney, NSW, Australia.
Case Rep Infect Dis ; 2016: 1841529, 2016.
Article en En | MEDLINE | ID: mdl-28127479
A 21-year-old Bangladesh-born man presented with a month history of evolving neurological symptoms in the context of a six-month history of fever, night sweats, and axillary lymphadenopathy. He was subsequently diagnosed with multiple multidrug resistant intracranial tuberculomata and was successfully treated over two years. Intracranial multidrug resistant tuberculosis has a high mortality and successful treatment is rarely reported. Management is complex and requires consideration of the penetration and likely effect of antituberculous agents within the central nervous system. We discuss the role of various antituberculous agents, the duration of therapy, the utility of corticosteroids, the value of intrathecal and systemic therapy, and the need for rapid diagnosis.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Case Rep Infect Dis Año: 2016 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Egipto

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Case Rep Infect Dis Año: 2016 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Egipto